Want to see AU:EDE full AI Analyst Report?
Eden Innovations (EDE) AI Stock Analysis
Eden Innovations
(ASX:EDE)
The overall score of 37 reflects a company in severe financial distress. The most significant factors are the deeply unprofitable and cash-burning operations, which show no clear path to self-sufficiency. This is compounded by a bearish technical trend with the stock price below all key moving averages. While the balance sheet has recently deleveraged, this is a secondary factor that does not offset the fundamental risk of continuous value destruction.
Eden Innovations (EDE) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 746.85M
- Dividend Yield
- ―
- Average Volume (3M)
- 1.69M
- Price to Earnings (P/E)
- -0.1
- Beta (1Y)
- 0.80
- Revenue Growth
- -18.73%
- EPS Growth
- 62.58%
- Country
- Australia
- Employees
- 35
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Industrial - Machinery
Eden Innovations Business Overview & Revenue Model
Company Description
Eden Innovations Ltd specializes in providing environmentally conscious technological solutions. The company is involved in the creation, production, and sales of several key products, including EdenCrete, a concrete admixture enhanced with carbon na...
Eden Innovations Financial Statement Overview
Summary
Financial performance is critically weak. The income statement shows massive, persistent losses with a net profit margin of -252% and volatile gross margins. Cash flow is deeply negative, with operating and free cash outflows exceeding net losses, indicating real cash destruction. The only mitigating factor is a recently improved balance sheet with low leverage, but this is overshadowed by the core operations' inability to generate profit or cash.
Income Statement
8Very NegativeBalance Sheet
35NegativeCash Flow
10Very Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.98M | 1.98M | 2.43M | 2.02M | 4.70M | 4.15M |
| Gross Profit | -2.35M | -2.35M | 1.68M | 1.39M | -2.17M | -3.36M |
| EBITDA | -3.97M | -3.97M | -3.93M | -4.83M | -15.08M | -4.49M |
| Net Income | -4.98M | -4.98M | -6.93M | -7.55M | -17.87M | -6.65M |
Balance Sheet | ||||||
| Total Assets | 19.09M | 19.09M | 17.84M | 19.07M | 17.00M | 25.79M |
| Cash, Cash Equivalents and Short-Term Investments | 5.41M | 5.41M | 561.18K | 975.20K | 2.53M | 1.55M |
| Total Debt | 1.23M | 1.23M | 16.34M | 12.79M | 10.21M | 4.91M |
| Total Liabilities | 5.08M | 5.08M | 19.59M | 15.10M | 12.28M | 6.30M |
| Stockholders Equity | 14.02M | 14.02M | -1.75M | 3.98M | 4.73M | 19.49M |
Cash Flow | ||||||
| Free Cash Flow | -4.61M | -4.61M | -3.70M | -5.27M | -5.11M | -7.51M |
| Operating Cash Flow | -4.49M | -4.49M | -3.70M | -5.22M | -4.17M | -6.03M |
| Investing Cash Flow | 5.93M | 5.93M | -305.20K | -586.79K | -940.93K | -1.48M |
| Financing Cash Flow | 3.53M | 3.53M | 3.59M | 4.26M | 6.09M | 6.78M |
Eden Innovations Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:EDE, the sentiment is Negative. The current price of 0.05 is below the 20-day moving average (MA) of 0.06, below the 50-day MA of 0.07, and below the 200-day MA of 0.13, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 47.07 is Neutral, neither overbought nor oversold. The STOCH value of 65.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:EDE.
Eden Innovations Peers Comparison
Overall Rating
AU:DEM67Neutral
AU:CWY66Neutral
AU:PET45Neutral
AU:EGL43Neutral
AU:ECT38Underperform- AU:EDE37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| AU:DEM | 67Neutral | AUD 36.00M | -32.35 | -7.59% | ― | 23.31% | 50.00% |
| AU:CWY | 66Neutral | AUD 6.73B | 68.18 | 3.26% | 2.28% | 13.49% | -37.41% |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| AU:PET | 45Neutral | AUD 5.00M | -1.63 | -48.20% | ― | 308.85% | -44.44% |
| AU:EGL | 43Neutral | AUD 28.73M | -4.97 | -14.21% | ― | -0.09% | -228.23% |
| AU:ECT | 38Underperform | AUD 38.13M | -5.74 | -27.29% | ― | ― | 29.52% |
| AU:EDE | 37Underperform | AUD 36.02M | -0.10 | -39.26% | ― | -18.73% | 62.58% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:EDE | Eden Innovations Ltd | 0.06 | 0.00 | 1.79% | |
| AU:PET | Phoslock Environmental Technologies Limited | 0.01 | -0.02 | -66.67% | |
| AU:CWY | Cleanaway Waste Management Ltd. | 3.00 | 0.52 | 20.97% | |
| AU:EGL | Environmental Group Limited | 0.07 | -0.16 | -68.09% | |
| AU:ECT | Environmental Clean Technologies Limited | 0.09 | -0.03 | -29.17% | |
| AU:DEM | De.mem Ltd. | 0.11 | 0.00 | 0.00% |
Eden Innovations Corporate Events
Eden Innovations Delivers Strong U.S. Growth and Expands EdenCrete Footprint
Eden Innovations reported a strong start to FY2027, with U.S. quarterly sales rising to US$381,612, more than two and a half times the prior year’s comparable period, driven by a 247% jump in OptiBlend revenue and 60% growth in EdenCrete sales....
Eden Innovations Passes US$1m Milestone With Ecuador Orders, Eyes Wider South American Push
Eden Innovations has secured another significant order from Holcim Ecuador for its EdenCrete Pz7 concrete admixture, worth US$334,110 (about A$475,000), bringing cumulative orders from this customer since May 2024 to just over US$1 million. The repea...
Eden Innovations Expands U.S. Project Pipeline as EdenCrete Pz7 Gains Traction
Eden Innovations reports a growing pipeline of significant U.S. construction projects using its EdenCrete Pz7 product, driven by an expanding network of bulk storage and dispensing installations at ready-mix concrete plants. Once EdenCrete Pz7 is int...
Eden Innovations Sets Date and Electronic Access for 2026 AGM
Eden Innovations Ltd has called its 2026 Annual General Meeting of shareholders for 3.00 p.m. AWST on 25 November 2026 at the company’s offices on Level 15, 197 St Georges Terrace in Perth, Western Australia. The notice of meeting, explanatory...
Eden Innovations Sets Key Dates for 2026 AGM and Director Nominations
Eden Innovations Ltd has scheduled its 2026 Annual General Meeting for 25 November 2026 in Perth, Western Australia, with formal meeting materials to be released to shareholders in line with regulatory and constitutional requirements. The company has...
Eden Innovations Tables Comprehensive 2026 Annual Report
Eden Innovations Limited has released its annual report for the year ended 30 June 2026, covering the operations of the company and its controlled entities. The report outlines a review of operations, a section on innovations, and full consolidated f...
Eden Innovations Cuts Losses and Clears Debt as OptiBlend Sales Rise
Eden Innovations reported a 19% fall in revenue to $1.98 million for the year to 30 June 2026, with EdenCrete sales down and OptiBlend revenue up 10% on demand from data centre back-up power customers in the U.S. The net loss after tax narrowed to $4...
Eden Innovations Boosts Managing Director’s Equity Through Share and Performance Rights Issuance
Eden Innovations Ltd has updated the market on changes to Managing Director Allan Larsen’s indirect holdings, reflecting adjustments to his equity-based compensation arrangements. The director’s interests are held through a family trust s...
Eden Innovations Sets September Expiry for 29 Million ASX-Listed Options
Eden Innovations has notified holders that 29,113,998 quoted options, exercisable at $0.18 each under the ASX code EDEOD, will expire at 5:00pm AWST on 11 September 2026, with official quotation to cease on 7 September 2026. Option holders may exerci...
Eden Innovations Issues Shares to Settle Director Fees and Loans
Eden Innovations Ltd is an Australia-based company listed on the ASX under the ticker EDE, operating in the industrial technology and materials sector. The company focuses on developing and commercialising innovative products and solutions, with its...
Eden Innovations Issues 21 Million Unquoted Performance Rights Under Incentive Scheme
Eden Innovations Ltd has announced the issuance of 21,000,000 unquoted Performance Rights, expiring on 4 August 2029, under its employee incentive scheme. The move reinforces the company’s use of long-term equity incentives to align employee in...
Eden Innovations Issues 3 Million Unquoted Options in Strategic Equity Move
Eden Innovations Ltd has issued 3 million unquoted options in three equal tranches, each with different exercise prices of $0.20, $0.30 and $0.40, all expiring on 4 August 2028. The options form part of previously announced transactions and are not i...
Eden Innovations Issues Large Tranche of Unquoted Options and Performance Rights
Eden Innovations has issued a significant tranche of unquoted equity securities, comprising 10 million unlisted options exercisable at $0.25 expiring in August 2029, 25 million unlisted options exercisable at $0.35 expiring in August 2030, and 5 mill...
Eden Innovations Issues 71.25 Million New Unlisted Options
Eden Innovations Ltd, an ASX-listed entity under ticker EDE, has filed a notification regarding changes to its unquoted equity securities. The release is focused on the company’s capital management actions, with no further details on its operat...
Eden Innovations Seeks ASX Quotation for Over 20 Million New Shares
Eden Innovations Ltd, listed on the ASX under the code EDE, operates in the innovation-driven technology space and raises equity capital through ordinary fully paid shares. Its focus on commercialising new solutions is underpinned by regular access t...
Eden Innovations Seeks ASX Quotation for Additional Ordinary Shares
Eden Innovations Ltd has applied for quotation on the ASX of 34,669 ordinary fully paid shares, to be issued on 3 August 2026. The new securities arise from the exercise or conversion of existing options or other convertible instruments, slightly inc...
Eden Innovations ramps up EdenCrete rollout and enters FY2027 debt-free
Eden Innovations reported strong quarterly progress, driven by accelerating adoption of its EdenCrete Pz7 dosage systems across North American ready-mix concrete plants and expansion into new U.S. states, Canada, and ongoing trials in India and other...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 16, 2026